Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify out of up to three doses a safe and effective dose
of Botulinum toxin type A for an injection into one side of the soft palate to treat snoring.
Phase:
Phase 2
Details
Lead Sponsor:
Merz Pharmaceuticals GmbH
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA Pharmaceutical Solutions